Skip to main content
Year archive

Orexo — 2011 filings

All 65 regulatory filings released by Orexo (ORX) in 2011, sourced directly from the official regulator.

65 Filings
2011 Period
2011 filings (65)
Filing Released Lang
Positiva studieresultat för OX27
Regulatory Filings
2011-12-20 Swedish
Positive study results for OX27
Regulatory Filings
2011-12-20 English
Orexo och Uppsala universitet får Vetenskapsrådets anslag för keramprojekt
Regulatory Filings
2011-11-30 Swedish
Orexo and Uppsala University receive Swedish Research Council grant for bioceramics project
Regulatory Filings
2011-11-30 English
Interim / Quarterly Report 2011
Interim / Quarterly Report 9M 2011
2011-11-09 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report 9M 2011
2011-11-09 English
Valberedning inför Orexos årsstämma 2012 och finansiell kalender 2011/2012
Board/Management Information
2011-10-11 Swedish
Nomination Committee prior to Orexo’s Annual General Meeting 2012 and Financial calendar 2011/2012
Report Publication Announcement
2011-10-11 English
Orexo utser Peter Edman till chef för forskning och utveckling
Board/Management Information
2011-10-04 Swedish
Orexo appoints Peter Edman as Chief Scientific Officer
Board/Management Information
2011-10-04 English
Orexo announces positive results supporting OX219 for treatment of opioid dependence
Earnings Release Q3 2011
2011-09-21 English
Orexo meddelar positiva resultat för OX219 för behandling av opioidberoende
Legal Proceedings Report
2011-09-21 Swedish
Orexo strengthens its commercial knowhow and appoints Nikolaj Sørensen as Chief Commercial Officer
Board/Management Information
2011-09-16 English
Orexo stärker den kommersiella kompetensen och utser Nikolaj Sørensen till Chief Commercial Officer
Board/Management Information
2011-09-16 Swedish
Orexo utser Carl-Johan Blomberg till ny CFO
Board/Management Information
2011-08-31 Swedish
Orexo appoints Carl-Johan Blomberg as new Chief Financial Officer
Board/Management Information
2011-08-31 English
Earnings Release 2011
Earnings Release H1 2011
2011-08-10 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report H1 2011
2011-08-10 English
Ny ägarbild i Orexo AB – nytt antal aktier och röster
Declaration of Voting Results & Voting Rights Announcements
2011-07-29 Swedish
Changes in ownership in Orexo AB – new number of shares and votes
Declaration of Voting Results & Voting Rights Announcements
2011-07-29 English
Sublinox (Edluar) approved in Canada
Regulatory Filings
2011-07-25 English
Sublinox (Edluar) godkänt i Kanada
Regulatory Filings
2011-07-25 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-07-18 English
Major Shareholding Notification 2011
Major Shareholding Notification
2011-07-15 English
Orexo blir världsledande inom diagnostiska utandningstest genom förvärv
M&A Activity
2011-07-14 Swedish
Orexo takes leading position in diagnostic breath tests through acquisition
M&A Activity
2011-07-14 English
Major Shareholding Notification 2011
Major Shareholding Notification
2011-06-30 English
Orexo announces successful completion of rights issue providing gross proceeds of about SEK 250 million
Share Issue/Capital Change
2011-06-29 English
Orexos meddelar framgångsrikt avslutad nyemission om cirka 245 MSEK
Share Issue/Capital Change
2011-06-29 Swedish
Orexo announces addendum to prospectus made public
Capital/Financing Update
2011-06-15 English
Orexo offentliggör tilläggsprospekt
Capital/Financing Update
2011-06-15 Swedish
Abstral® lanseras i Kanada
Regulatory Filings
2011-06-14 Swedish
Abstral® launches in Canada
Regulatory Filings
2011-06-14 English
Orexo announces prospectus regarding rights offering
Capital/Financing Update
2011-05-30 English
Orexo offentliggör prospekt avseende nyemission
Capital/Financing Update
2011-05-30 Swedish
Kommuniké från extra bolagsstämma i Orexo AB den 27 maj 2011
Share Issue/Capital Change
2011-05-27 Swedish
Notice of Extraordinary General Meeting in Orexo
AGM Information
2011-05-04 English
Kallelse till extra bolagsstämma i Orexo
AGM Information
2011-05-04 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Q1 2011
2011-05-04 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Q1 2011
2011-05-04 English
Orexo AB announces that Robin Wright resigns as CFO
Board/Management Information
2011-04-11 English
Orexo AB meddelar att Robin Wright avgår som finanschef
Board/Management Information
2011-04-11 Swedish
Report from Orexo AB’s Annual General Meeting, 7 April 2011
AGM Information
2011-04-07 English
Kommuniké från Orexo AB:s årsstämma den 7 april 2011
AGM Information
2011-04-07 Swedish
Abstral® är lanserad och nu tillgänglig i USA
Regulatory Filings
2011-04-04 Swedish
Abstral® launched and now available in the United States
Earnings Release FY 2011
2011-04-04 English
Orexo har framgångsrikt genomfört den första kliniska studien för OX51
Earnings Release Q1 2011
2011-03-31 Swedish
Orexo announces successful completion of the first clinical trial in OX51
Regulatory Filings
2011-03-31 English
Annual Report 2010
Annual Report FY 2010
2011-03-17 Swedish
Notice of Annual General Meeting of Orexo
AGM Information
2011-03-08 English
Kallelse till årsstämma i Orexo
AGM Information
2011-03-08 Swedish
Abstral® approved in Canada
Regulatory Filings
2011-02-22 English
Abstral® godkänt i Kanada
Regulatory Filings
2011-02-22 Swedish
Report from Orexo AB’s extraordinary shareholders’ meeting, 16 February 2011
Remuneration Information
2011-02-17 English
Kommuniké från extra bolagsstämma i Orexo AB den 16 februari 2011
AGM Information
2011-02-17 Swedish
Interim / Quarterly Report 2010
Interim / Quarterly Report FY 2010
2011-02-16 English
Earnings Release 2010
Earnings Release FY 2010
2011-02-16 Swedish
Orexo och Invida ingår avtal avseende Abstral™ i Asien och Stillahavsområdet
M&A Activity
2011-01-14 Swedish
Orexo and Invida jointly announce agreement for Abstral™ in Asia Pacific
Regulatory Filings
2011-01-14 English
Anders Lundström utsedd till ny VD för Orexo
Board/Management Information
2011-01-13 Swedish
Anders Lundström to be the new CEO of Orexo
Board/Management Information
2011-01-13 English
Notice of Extraordinary General Meeting of Orexo AB, February 16, 2011
AGM Information
2011-01-11 English
Kallelse till Orexo ABs extra bolagsstämma den 16 februari 2011
Capital/Financing Update
2011-01-11 Swedish
FDA Approval for Abstral (Fentanyl) Sublingual Tablets - US launch planned for Q1 2011
Regulatory Filings
2011-01-10 English
Abstral (sublingualt fentanyl) godkänt av FDA i USA – USA-lansering planerad första kvartalet 2011
Regulatory Filings
2011-01-10 Swedish